Price$0.24-0.03 (-11.71%)
01:30 PM07:45 PM
News · 26 weeks97-37%
2026-01-182026-07-12
Mix7390d
- Other35(48%)
- Insider17(23%)
- Market10(14%)
- SEC Filings10(14%)
- M&A1(1%)
Latest news
25 items- SECSEC Form S-8 filed by Cosmos Health Inc.S-8 - Cosmos Health Inc. (0001474167) (Filer)
- PRCosmos Health Share Buyback Expands to 5.11 Million Shares; Continues Open Market RepurchasesCHICAGO, July 17, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has repurchased an additional 274,000 shares of its common stock in the open market at an average price of approximately $0.2554 per share. The Company has now repurchased a total of 5,112,000 shares for approximately $1.11 million under its previously announced share repurchase program of up to $5 million. Under the program, Cosmos Health may repurchase shares from time to time in the open market, through privately negotiated transactions, or through other permitted means, in accordance with S
- SECCosmos Health Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - Cosmos Health Inc. (0001474167) (Filer)
- PRCosmos Health Share Buyback Surpasses $1 Million, Reaching 4.84 Million Shares; Continues Open Market RepurchasesCHICAGO, July 16, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has repurchased an additional 250,000 shares of its common stock in the open market at an average price of approximately $0.2782 per share. The Company has now repurchased a total of 4,838,000 shares for approximately $1.04 million under its previously announced share repurchase program of up to $5 million. Under the program, Cosmos Health may repurchase shares from time to time in the open market, through privately negotiated transactions, or through other permitted means, in accordance with S
- PRCosmos Health Share Buyback Surpasses 4.5 Million Shares; Continues Open Market RepurchasesCHICAGO, July 15, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has repurchased an additional 100,000 shares of its common stock in the open market at an average price of approximately $0.2928 per share. The Company has now repurchased a total of 4,588,000 shares for approximately $970,000 under its previously announced share repurchase program of up to $5 million. Under the program, Cosmos Health may repurchase shares from time to time in the open market, through privately negotiated transactions, or through other permitted means, in accordance with SEC Ru
- PRCosmos Health Share Buyback Expands to 4.49 Million Shares; Continues Open Market RepurchasesCHICAGO, July 14, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has repurchased an additional 133,000 shares of its common stock in the open market at an average price of approximately $0.298 per share. The Company has now repurchased a total of approximately 4,488,000 shares for approximately $941,000 under its previously announced share repurchase program of up to $5 million. Under the program, Cosmos Health may repurchase shares from time to time in the open market, through privately negotiated transactions, or through other permitted means, in accordanc
- PRCosmos Health Share Buyback Reaches 4.36 Million Shares; Continues Open Market RepurchasesCHICAGO, July 13, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has repurchased an additional 215,000 shares of its common stock in the open market at an average price of approximately $0.325 per share. The Company has now repurchased a total of 4,355,000 shares for approximately $901,000 under its previously announced share repurchase program of up to $5 million. Under the program, Cosmos Health may repurchase shares from time to time in the open market, through privately negotiated transactions, or through other permitted means, in accordance with SEC Rul
- PRCosmos Health Accelerates Prescription Medicine Strategy with Libytec Partnership to Commercialize DIABIT-IS X in GreeceCosmos Health will supply DIABIT-IS X (sitagliptin), while Libytec handles distribution and promotion in GreeceFive-year agreement expected to contribute to revenue and cash-flow visibilityAs a prescription medicine, DIABIT-IS X is expected to be accessible to patients through Greece's national health insurance system, broadening its potential reachDIABIT-IS X is a generic alternative to Merck's Januvia®, which with Janumet® generated approximately $4.5 billion in combined global sales in 2022Positions Cosmos Health in the large and established European sitagliptin market CHICAGO, July 13, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a dive
- PRCosmos Health Launches Subscription ModelSubscription model already launched with NOOR Collagen in the United StatesEarly data shows a repeat purchase rate above 60% at high margins in excess of 50%Model is designed to drive stronger loyalty, greater lifetime value, and more predictable cash-flow visibilityCompany plans to extend the subscription model to additional Cosmos Health products globally, with further initiatives already underway CHICAGO, July 10, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has launched a subscription-based purchasing model for its proprietary consumer health brands.
- PRCosmos Health Expands Share Buyback to 4.14 Million Shares; Continues Open Market RepurchasesCHICAGO, July 09, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has repurchased an additional 80,000 shares of its common stock in the open market at an average price of approximately $0.2503 per share. The Company has now repurchased a total of 4,140,000 shares for approximately $831,000 under its previously announced share repurchase program of up to $5 million. Under the program, Cosmos Health may repurchase shares from time to time in the open market, through privately negotiated transactions, or through other permitted means, in accordance with SEC Rul
- PRCosmos Health Share Buyback Surpasses 4 Million Shares; Continues Open Market RepurchasesCHICAGO, July 08, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has repurchased an additional 190,000 shares of its common stock in the open market at an average price of approximately $0.2805 per share. The Company has now repurchased a total of 4,060,000 shares for approximately $811,000 under its previously announced share repurchase program of up to $5 million. Under the program, Cosmos Health may repurchase shares from time to time in the open market, through privately negotiated transactions, or through other permitted means, in accordance with SEC Ru
- PRCosmos Health Share Buyback Expands to 3.87 Million Shares; Continues Open Market RepurchasesCHICAGO, July 07, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has repurchased an additional 230,000 shares of its common stock in the open market at an average price of approximately $0.2539 per share. The Company has now repurchased a total of 3,870,000 shares for approximately $758,000 under its previously announced share repurchase program of up to $5 million. Under the program, Cosmos Health may repurchase shares from time to time in the open market, through privately negotiated transactions, or through other permitted means, in accordance with SEC Ru
- PRCosmos Health Reports Preliminary Record Q2 and H1 2026 Revenue, Up Over 30% Year-Over-Year; Continues Open Market Share RepurchasesRecord Q2 2026 revenue of approximately $19.4 million, up approximately 31.5% year-over-year from $14.75 million in Q2 2025Record first-half 2026 revenue of approximately $37.3 million, up approximately 31% from $28.46 million in H1 20253,640,000 shares repurchased as of July 6, 2026 for approximately $700,000 under the Company's $5 million buyback program, with open market purchases ongoing CHICAGO, July 07, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today provided a business update on its second quarter and first-half revenue performance and share repurchase activity. Record
- PRCosmos Health Share Buyback Increases to 3.64 Million Shares; Continues Open Market PurchasesCHICAGO, July 06, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has repurchased an additional 220,000 shares of its common stock in the open market at an average price of approximately $0.2229 per share, continuing the buyback activity carried out under its ongoing repurchase program. The Company has now repurchased a total of 3,640,000 shares for approximately $700,000 under its previously announced share repurchase program of up to $5 million. Under the program, Cosmos Health may buy back shares from time to time in the open market, through privately nego
- SECCosmos Health Inc. filed SEC Form 8-K: Other Events, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Cosmos Health Inc. (0001474167) (Filer)
- PRCosmos Health Expands Buyback to 3.42 Million Shares With Additional 770,000-Share Repurchase; Continues Open Market PurchasesCHICAGO, July 02, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has repurchased an additional 770,000 shares of its common stock in the open market at an average price of approximately $0.1956 per share, extending the buyback activity it began this week. The Company has now repurchased a total of 3,420,000 shares for approximately $650,000 under its previously announced share repurchase program of up to $5 million. Under the program, Cosmos Health may buy back shares from time to time in the open market, through privately negotiated transactions, or through
- PRCosmos Health Completes Initial Repurchase of 2.65 Million Shares for $500,000; Continues Open Market Buybacks at Current PaceCHICAGO, July 01, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has repurchased 2,650,000 shares of its common stock for a total of $500,000 in the open market, at an average price of approximately $0.1887 per share. The repurchases were made pursuant to the share repurchase program of up to $5 million announced on June 30, 2026, under which the Company may repurchase shares from time to time in the open market, through privately negotiated transactions, or through other permitted means in accordance with SEC Rules 10b5-1 and 10b-18 and other applicable res
- PRCosmos Health Authorizes Up to $5 Million Share Repurchase ProgramCHICAGO, June 30, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its Board of Directors has authorized a share repurchase program of up to $5 million of the Company's common stock. Cosmos Health may repurchase shares from time to time in the open market, through privately negotiated transactions, or through other permitted means in accordance with SEC Rules 10b5-1 and 10b-18 and other applicable restrictions. The timing and total amount of repurchases will depend on market conditions, corporate and regulatory requirements, prevailing stock prices, and other con
- PRCosmos Health Signs Distribution Agreement With IMC, Owner of Qatar's Largest Pharmacy Chain; Secures Initial Purchase Order of 31,000 Sky Premium Life UnitsCHICAGO, June 26, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced a distribution agreement with International Medical Company ("IMC") to expand its presence in the State of Qatar for its proprietary Sky Premium Life® line of nutraceuticals and food supplements. In connection with the agreement, IMC has placed an initial purchase order of 31,000 units. Founded in 1998, IMC is Qatar's fastest-growing pharmaceutical retailer and distributor and one of the sector's leading employers, with a team of over 1,400 operating across its Sales & Marketing, Pharmacy, and Consume
- PRCosmos Health’s C-Sept PRO Gains Strong Traction Across Leading Greek Public and Private Hospital Groups, With Annualized Sales Poised to Exceed $1.3 Million at Approximately 72% Gross MarginCHICAGO, June 24, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today provided an update on the growing momentum of C-Sept™ PRO, a proprietary antiseptic solution from its high-margin infection-control portfolio, across leading public and private hospital groups in Greece. C-Sept PRO has generated average monthly sales exceeding $93,000 over the past six months, accelerating to more than $108,000 per month over the past three months. This momentum places the product on track for annualized sales of over $1.3 million, generating approximately $0.9 million in annualized gross pr
- PRCosmos Health Signs Agreement to Deploy Artificial Intelligence (AI)-Powered Call Center to Optimize Order Intake, Customer Communications, and Operating EfficiencyCHICAGO, June 23, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has signed an agreement to deploy an Artificial Intelligence (AI)-powered call center to support customer communications, including order intake and routine support functions, marking the latest step in the Company’s ongoing integration of AI across its operations. Under the agreement, the Company’s wholly owned pharmaceutical distribution subsidiary, CosmoFarm S.A. ("CosmoFarm"), will deploy an AI-powered voice and communications platform to manage and enhance its customer communications. The
- PRCosmos Health Builds Contract Manufacturing Orderbook to Over 25 Million Units; Division Positioned to Generate Over $10 Million in Recurring Annual ProfitCumulative orderbook of over 25 million units secured through wholly owned subsidiary Cana Laboratories across multiple EU and international partners.Multi-year agreements extending up to 10 years provide recurring revenue and long-term cash flow visibility.Diversified across nine therapeutic categories, reducing dependence on any single product or partner.Produced at Cana’s 54,000 sq. ft., EU-GMP-licensed, EMA-certified Athens facility, following an approximately $5.5 million upgrade program and a new ACG capsule-filling line.Division expected to generate over $10 million in recurring annual profit at full capacity. CHICAGO, June 22, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos H
- PRCosmoFarm Delivers Record Q2 2026 Revenue of Over $15M, Representing $60+ Million Annualized Run-Rate; Adds Over 80 Pharmacies and Expands AI Automation and Facility CapacityCHICAGO, June 18, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its wholly owned subsidiary, CosmoFarm S.A. ("CosmoFarm"), delivered record revenue of over $15 million in the second quarter of 2026, representing an annualized run-rate of over $60 million. CosmoFarm added more than 80 new pharmacies to its distribution network during the period, continuing the strong customer growth that has made it one of the leading pharmaceutical wholesalers in the greater Athens area. To support this accelerating growth, Cosmos Health is increasing capital expenditure at C
- PRCosmos Health Signs 2.86 Million-Unit Contract Manufacturing Agreement With Pharmex S.A. Across Three Dermatological ProductsCHICAGO, June 17, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that, through its wholly owned subsidiary Cana Laboratories S.A. ("Cana"), it has entered into a five-year contract manufacturing agreement with Pharmex S.A. ("Pharmex") to produce three pharmaceutical products. Under the agreement, Cana will manufacture the following products for Pharmex at its EU-GMP-licensed, EMA-certified facility, with combined volumes of approximately 2.86 million units over the five-year term. ProductActive IngredientPharmaceutical FormAnnual UnitsFive-Year TotalBETAFUSIN®Betame
- INSIDERChief Financial Officer Terzis Georgios bought $42,000 worth of shares (168,135 units at $0.25), increasing direct ownership by 8% to 2,235,398 units (SEC Form 4)4 - Cosmos Health Inc. (0001474167) (Issuer)
COSM FAQ
5 questionsWhat does Cosmos Health Inc. do?
Cosmos Holdings Inc. operates as a vertically integrated pharmaceutical company. It offers proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter (OTC) medications, health care, baby products, medical devices, and other products through its distribution channels and e-commerce market place. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece, and the United Kingdom; and warehousing facility. It serves wholesale pharmaceutical distributors and...Where does COSM stock trade?
Cosmos Health Inc. (COSM) is listed on NASDAQ.What sector and industry is COSM in?
Cosmos Health Inc. operates in the Health Care sector, Other Pharmaceuticals industry.What companies are similar to COSM?
Notable peers in the same industry include MCK (McKesson Corporation), COR (Cencora Inc.), CAH (Cardinal Health Inc.), ABC (AmerisourceBergen Corporation), CVET (Covetrus Inc.). Compare COSM side-by-side with any of them on Quantisnow.How can I track COSM on Quantisnow?
Quantisnow aggregates Cosmos Health Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow COSM to receive live email and push alerts on every new disclosure.